Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Dexamethasone sodium phosphate encapsulated in human erythrocytes

EU orphan designation number: EU/3/04/230   
Active ingredient: Dexamethasone sodium phosphate encapsulated in human erythrocytes
Indication: Treatment of cystic fibrosis
Sponsor: Erydel S.p.A.
Via Sasso, 36 , 61029 Urbino, Italia

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
25/10/2004 Orphan designation EMEA/OD/039/04 (2004)4191 of 20/10/2004
14/03/2005 Change of name and/or address of sponsor
15/12/2005 Change of name and/or address of sponsor
12/01/2010 Transfer of orphan designation EMEA/OD/039/04/T/01 (2010)69 of 08/01/2010